Moderna (MRNA)

Capital Expenditure

-$171.00M

TTM · Period ending: · USD

MRNA logo

MRNA Capital Expenditure

Latest reported-$171.00M
MRNA TTM CapEx (-$58.40M → -$171.00M)
High-resolution chart · PNG

MRNA capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-171,000,000
-137,000,000
-202,000,000
-685,000,000
-803,000,000
-982,000,000
-1,051,000,000
-749,000,000
-738,000,000
-790,000,000
-707,000,000
-579,000,000
-528,000,000
-381,000,000
-400,000,000
-428,000,000
-438,000,000
-381,000,000
-284,000,000
-187,301,000
-107,593,000
-96,225,000
-67,448,000
-50,809,000
-38,228,000
-30,182,000
-31,554,000
-38,529,000
-57,958,000
-81,452,000
-105,766,000
-104,089,000
-107,047,000
-81,638,500
-58,401,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.